Serial 86734322
Live / Registered — Registered and renewed (as of 21 Nov 2025)
What this means for you
Registered since 21 Jun 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jun 2026).
Record
- Serial number
- 86734322
- Registration number
- 4985344
- Mark type
- Design / logo
- Filed
- 24 Aug 2015
- Published for opposition
- 24 Nov 2015
- Registered
- 21 Jun 2016
- Next maintenance due
- 21 Jun 2026
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatories; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in rheumatology
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 21 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Nov 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Nov 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Aug 2025 — TEAS SECTION 8 & 9 RECEIVED
- 21 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 May 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Nov 2021 — TEAS SECTION 8 & 15 RECEIVED
- 21 Jun 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Jun 2016 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 May 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 May 2016 — STATEMENT OF USE PROCESSING COMPLETE